#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cystic fibrosis lung Head and neck cancer Richter's syndrome Astrocytoma malignant Immunoglobulin G4 related disease Bulbospinal muscular atrophy congenital Vaginal cancer Transitional cell cancer of the renal pelvis and ureter Gastrointestinal neuroendocrine tumour Acute lymphocytic leukaemia recurrent Liposarcoma recurrent Soft tissue necrosis Pseudoxanthoma elasticum Malformation venous Arrhythmogenic right ventricular dysplasia More trials…

    Learn about Rare Diseases

    Angiosarcoma recurrent Chondrosarcoma metastatic – Treatment X-linked lymphoproliferative syndrome – Diagnostics Idiopathic inflammatory myopathy Synovial sarcoma metastatic – Basic Information Atypical teratoid/rhabdoid tumour of CNS – Diagnostics Atypical haemolytic uraemic syndrome – Diagnostics Acquired haemophilia – Trials in Disease Antisynthetase syndrome – Basic Information Alexander disease – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Dabrafenib Itepekimab GRAPHITE Phenazone Cipaglucosidase Alfa Quavonlimab Cefotaxime Sodium Digoxin Acalabrutinib Benzylpenicillin Cefepime Hydrochloride Amoxicillin Ianalumab Ceftriaxone Sodium Taletrectinib GOCATAMIG Bempikibart Viltolarsen Dabrafenib Mesylate His203-Crm197 More therapies…

    Learn about Your Condition

    Ewing's sarcoma recurrent Renal cancer recurrent Pulmonary venous thrombosis Altered state of consciousness Meningioma Onychomycosis Tardive dyskinesia Ectopic pregnancy Cardiac failure acute Eye disorder MELAS syndrome Post-traumatic stress disorder Burning mouth syndrome Adenocarcinoma Macular oedema More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Universitetssykehuset Nord-Norge HF

Universitetssykehuset Nord-Norge HF

Hansine Hansens Veg 67, Tromsø, 9019, Norway

Want to learn more about this study or check if you can participate? Contact us.

  • Study Comparing Avatrombopag and Rituximab for Adults with Immune Thrombocytopenia Not Responding to Corticosteroids

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Immune thrombocytopenia
    Investigated Drugs:
    • Avatrombopag
    • Rituximab
    Norway

  • Study on Fasudil Hydrochloride for Memory Loss Prevention in Early Alzheimer’s Disease Patients

    Recruiting

    2 1
    Investigated Diseases:
    • Cognitive disorder
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • Fasudil Hydrochloride
    Norway

  • Study on Ketamine and Midazolam for Adults with Depression and Alcohol Use Disorder

    Recruiting

    1 1 1
    Investigated Drugs:
    • Midazolam Hydrochloride
    • Ketamine
    Norway

  • Study on the Effectiveness of Volrustomig in Women with High-Risk Locally Advanced Cervical Cancer After Chemoradiation Therapy

    Recruiting

    3 1 1
    Investigated Diseases:
    • Cervix carcinoma
    Investigated Drugs:
    • Infliximab
    • Mycophenolate Mofetil
    • Volrustomig
    Denmark Germany Italy Norway Poland Spain

  • Study on Lomustine and Temozolomide for Newly Diagnosed Glioblastoma Patients

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Temozolomide
    Austria Denmark Norway Sweden

  • Study on Lymphoblastic Lymphoma Treatment in Children and Adolescents Using Dexamethasone, Prednisone, and PEG-Asparaginase

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Vindesine Sulfate
    • Ifosfamide
    • Cytarabine
    Austria Belgium Czechia Denmark Finland Germany +8

  • Study on ZED1227 for Improving Symptoms in Celiac Disease Patients on a Gluten-Free Diet

    Recruiting

    2 1
    Investigated Drugs:
    • Methyl (E,6S)-7-[[1-[2-(2-Ethylbutylamino)-2-Oxoethyl]-2-Oxopyridin-3-Yl]Amino]-6-[(3-Methylimidazole-4-Carbonyl)Amino]-7-Oxohept-2-Enoate
    Austria Croatia Finland Germany Ireland Italy +5

  • Study of Dostarlimab After Chemoradiation for Adults with Advanced Unresected Head and Neck Cancer

    Recruiting

    3 1 1
    Investigated Diseases:
    • Squamous cell carcinoma of head and neck
    Investigated Drugs:
    • Dostarlimab
    Belgium Czechia France Germany Greece Hungary +7

  • Study on the Use of Mesenchymal Stem Cells and Sodium Chloride for Patients with Progressive Multiple Sclerosis

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Multiple sclerosis
    Investigated Drugs:
    • Mesenchymal Stromal Cells, Ex Vivo Cultured
    • Sodium Chloride
    Norway

  • Study of Tranexamic Acid Applied to Surgical Wounds to Prevent Bleeding Complications After Plastic Surgery in Adult Patients

    Recruiting

    3 1 1
    Investigated Diseases:
    • Post procedural complication
    Investigated Drugs:
    • Tranexamic Acid
    • Sodium Chloride
    Denmark Finland Norway
Previous Page
1 … 3 4 5 6 7 … 13
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!